The Netherlands in North Germany

The life science sector also showcased its strengths in front of the Dutch business delegation, which accompanied the royal couple Willem-Alexander and Máxima on its tour of North Germany as part of a two-day working visit. On a visit to Drägerwerke in Lübeck on March 19, the royal couple met selected representatives of the healthcare industry and discussed current topics. At the following presentation arranged by the Life Science Nord Cluster in the Emporio building in Hamburg three innovative firms and one research institute were able to showcase their products and activities.
  • The Hamburg company connected-health.eu GmbH is developing a hub for data traffic between doctors and patients via smartphones and won top prize in the category "Idea Contribution" of the app contest organized by the Hamburg Chamber of Commerce. Connected-health.eu was also one of the 50 startup finalists in the "CODE_n" competition at CeBIT.

  • The biotech firm KSK Diagnostics GmbH, supported by the Hamburg Innovationstarter Fund's "InnoRampUp" program, is aiming to develop a DNA analysis based on an especially fast point-of-care test.

  • Sonormed GmbH also receives funding from the "InnoRampUp" program. Its Tinnitracks product offers a tinnitus therapy endorsed by the latest neuroscientific findings and based on specially filtered music. Sonormed was a winner in the SXSW (South by Southwest) technology conference's startup competition in the U.S. in the digital health and life science category.

  • The field of research was represented by the Fraunhofer MEVIS Project Group from Lübeck, which uses image registration to combine and compare information from various patient images.

"As direct neighbors of the Netherlands, we are delighted to welcome the Dutch delegation and see this as an opportunity to showcase our strengths in life sciences, learn from each other and set the course for closer collaboration in the future," said Dr. Hinrich Habeck, Managing Director of Life Science Nord Management GmbH. At the following trade dinner, company representatives had the opportunity to exchange views and make new contacts. On 20 March, members of the delegation from the life sciences sector were shown the prototype of the world's first human scanner with MPI (magnetic particle imaging) technology during a visit to Philips Healthcare. The delegates' stay in Hamburg culminated in a North German-Dutch matchmaking event.

About the delegates' trip

The two-day trip entitled "Shared Challenges, Smart Solutions: Sharing Knowledge between Germany and The Netherlands on Smart Health" headed by the Dutch foreign trade minister Lilliane Ploumen focused on energy (especially wind energy), life sciences and health. In all, representatives from about 50 companies took part in the trip.

About Life Science Nord Management GmbH

As a cluster management agency, Life Science Nord Management GmbH networks medical technology, biotech and pharma under the Life Science Nord umbrella brand. The agency initiates and oversees projects, events and trade show appearances, thereby raising the cluster's visibility and strengthening the life science sector internally and externally. Attachments: · Further information, interview dates and photo material:
Life Science Nord Management GmbH
Simone Hauck, Marketing & PR Manager
Falkenried 88, 20251 Hamburg
Tel.: 040 - 471 96 -423
Fax: 040 - 471 96 -444
Email: hauck@lifesciencenord.de
Internet: www.lifesciencenord.de

More News

GQ Bio is pioneering a high-capacity adenovirus (HCAd) gene therapy vector platform that addresses some of the big challenges in the gene therapy field. (Picture: GQ Bio)
GQ Bio is pioneering a high-capacity adenovirus (HCAd) gene therapy vector platform that addresses some of the big challenges in the gene therapy field. (Picture: GQ Bio)

Pacira BioSciences Acquires GQ Bio

HTGF portfolio company GQ Bio, pioneering a high-capacity adenovirus gene therapy vector platform, was acquired by Pacira BioSciences, Inc. Pacira, the industry leader in its ...

Read more …
At its new premises in the tecHHub Hamburg, CrystalsFirst is significantly expanding its operations to foster greater synergy. (Picture: CrystalsFirst)
At its new premises in the tecHHub Hamburg, CrystalsFirst is significantly expanding its operations to foster greater synergy. (Picture: CrystalsFirst)

CrystalsFirst Scales Operations...

CrystalsFirst, a leading provider of advanced structural biology solutions and AI-driven drug discovery, is pleased to announce a multi-million-euro expansion of its laboratory infrastructure and ...

Read more …
medac has received FDA approval for treosulfan (Copyright Adobe Stock - Nicolas Hermbach)

Strategic cornerstone for medac: FDA approves treosulfan for alloHSCT

medac has received FDA approval for treosulfan as a new drug application with orphan drug designation prior to allogeneic hematopoietic stem cell transplantation (alloHSCT) in ...

Read more …